What's new
The drugs do work but cost too much
24 October 2024
This week Donanemab, a second new treatment that slows the progression of Alzheimer’s disease has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) but deemed too expensive by the National Institute for Health and Care Excellence (NICE) for widespread use in the NHS. At the same time, DPUK gathered in Nottingham for the latest in our Great Minds events to consider, in the absence of and in addition to accessible treatments, how can you live well with dementia?
International Data Access
3 October 2024
DPUK is committed to internationalising access to datasets. Professor John Gallacher recently addressed a Summit in Washington DC about the high value of data sharing to advance dementia research.
DPUK says ‘Grounds for optimism’ after ground-breaking lecanemab drug gets a UK license…but it won't be used in the NHS.
22 August 2024
Lecanemab gets a green light, but only limited use for patients in the UK.
DPUK takeaways from AAIC 2024
14 August 2024
Our DPUK team from AAIC 24 is regrouping now after a very busy week covering lots of ground. We asked a few of them to tell us their personal highlights and share the big news stories to emerge.
Our research
The DPUK Data Portal gives researchers rapid, secure access to millions of health research records.
Our Trials Delivery Framework matches public volunteers to the right dementia studies.
Our Experimental Medicine Incubator accelerates and de-risks the development of new treatments.
Featured research: Can our genes predict our likelihood of developing dementia?
A project led by researchers at Cardiff University is analysing data in the DPUK Data Portal to predict genetic risk of dementia, focusing on genes related to the brain's immune system.
Featured Researcher
Yasir Widatalla
Research Assistant, SHINE
Yasir works as a Research Assistant for the SHINE project based in Cambridge, where he undertakes various responsibilities. These include identifying and reaching out to suitable patients and volunteers for study participation. He is also tasked with scheduling MRI, PET, and/or M/EEG imaging studies as well as applying behavioural tests and utilizing neurophysiological/imaging instruments both in clinic settings and during research study visits.
Yasir holds an MBBS degree from Sudan and was awarded the prestigious Chevening Scholarship to pursue Clinical Neuroscience at UCL during the academic year 22/23. His project at UCL focused on Electrophysiology and involved the study of EEG/calcium imaging.
Yasir is also a BNA scholar in 2024 (British Neuroscience Association). With a strong ambition to become a neurologist specializing in neurophysiology, Yasir demonstrates a keen interest in advancing his expertise in this field
Work with us
Would you like to increase the international visibility of your data? Try our Data Portal.
Do you need well-characterised volunteers for your early-phase trial? Use our Trials Delivery Framework.
Is there a mechanism you would like to investigate? Explore our Experimental Medicine Incubator.